Prostate Cancer Clinical Trials in Shanghai, Shanghai Municipality
6 recruitingShanghai, Shanghai Municipality, China
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Prostate CancerProstatic Neoplasms
Merck Sharp & Dohme LLC1,440 enrolled274 locationsNCT06925737
Recruiting
Phase 1Phase 2
A Study of HRS-5041 Tablets Combined With Antitumor Therapy in Subjects With Advanced Prostate Cancer
Prostate Cancer
Jiangsu HengRui Medicine Co., Ltd.100 enrolled2 locationsNCT06568094
Recruiting
Phase 1Phase 2
Study of ACE-86225106 to Treat Patients With Advanced Solid Tumors
Breast CancerOvarian CancerProstate Cancer+3 more
Acerand Therapeutics (Shanghai) Limited298 enrolled14 locationsNCT06380660
Recruiting
Phase 1
Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors
Breast CancerOvarian CancerProstate Cancer+4 more
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd30 enrolled2 locationsNCT06666270
Recruiting
Phase 1Phase 2
Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer
Prostate Cancer
Sinotau Pharmaceutical Group32 enrolled2 locationsNCT06081686
Recruiting
Phase 2
Stereotactic Body Radiation Therapy for Spinal Metastases in Favorite Tumors
Breast CancerProstate Cancer
RenJi Hospital100 enrolled1 locationNCT03392233